526
Participants
Start Date
October 31, 2005
Primary Completion Date
April 30, 2007
Study Completion Date
April 30, 2007
montelukast (5mg QD)
Salmeterol/Fluticasone propionate Inhalation Powder (50/100mcg BID)
GSK Investigational Site, Caracas
GSK Investigational Site, Caracas
GSK Investigational Site, Caracas
GSK Investigational Site, Adana
GSK Investigational Site, Santa Fe
GSK Investigational Site, Ankara
GSK Investigational Site, México
GSK Investigational Site, Antalya
GSK Investigational Site, Mexico City
GSK Investigational Site, Bursa
GSK Investigational Site, Chihuahua City
GSK Investigational Site, Istanbul
GSK Investigational Site, Istanbul
GSK Investigational Site, Izmir
GSK Investigational Site, Guadalajara
GSK Investigational Site, Monterrey
GSK Investigational Site, Bogotá
GSK Investigational Site, Santiago de Cali
GSK Investigational Site, Buenos Aires
GSK Investigational Site, Capital Federal-Buenos Aires
GSK Investigational Site, Medellín
GSK Investigational Site, San José
GSK Investigational Site, Mexico City
GSK Investigational Site, México
GSK Investigational Site, Lima
GSK Investigational Site, Lima
Lead Sponsor
GlaxoSmithKline
INDUSTRY